Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease

Erin McMullen Jonaitis, Shorena Janelidze, Karly Alex Cody, Rebecca E. Langhough, Lianlian Du, Nathaniel A. Chin, Niklas Mattsson, Kirk J. Hogan, Bradley T. Christian, Tobey J. Betthauser, Oskar Hansson, Sterling C. Johnson
ISSN / E-ISSN
— / —
DOI
10.1093/braincomms/fcad057 ↗
Volume · Issue · Pages
5 · 2 · fcad057-fcad057
Publisher
Oxford University Press
Article URL
https://doi.org/10.1093/braincomms/fcad057 ↗
Article details
Unverified
Publication date (each date has its type and source)
02 Mar 2023
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date02 Mar 2023 OpenAlex

Keywords (as given): preclinical Alzheimer's disease; phosphorylated tau217; plasma biomarkers; blood-based diagnosis; amyloid PET; tau PET; Pittsburgh compound B; [18F]MK-6240; cognitive decline prediction; Wisconsin Registry for Alzheimer's Prevention; early detection of Alzheimer's disease; biomarker concordance

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized Y
Based on the recorded HEC dataset applicable to the article's publication date. Listed as Y in the HEC list for 2022–23.
Journal
Brain Communications
Publication date used
02 Mar 2023 (OpenAlex publication date)
Applicable HEC period
2022–23 (version 2) · 01 Jul 2022 – 30 Jun 2023
Category
Y
Recognition status
Recognized (OK_RECORD_FOUND)
Source
hjrs-2022-23 row 44220
Verification status
Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.